The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Sequential salvage chemotherapy for CDDP-refractory advanced testicular cancer: Japanese high-volume center experience.
Terukazu Nakamura
No relevant relationships to disclose
Yasunori Kimura
No relevant relationships to disclose
Takashi Ueda
No relevant relationships to disclose
Yoshio Naya
No relevant relationships to disclose
Fumiya Hongo
No relevant relationships to disclose
Tsuneharu Miki
No relevant relationships to disclose